Since the beginning of the Millennium Development Goals period and stretching out to the current Sustainable Development Goals period, pharmaceutical research and development (R&D) in maternal health has not been a global public health priority. During this...
Concept Foundation is happy to announce that Incepta Pharmaceuticals (Bangladesh) has been awarded WHO Prequalification of their intramuscular (IM) depot medroxyprogesterone acetate (DMPA) 150 mg/ml product.
WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
A third quality assured, generic DMPA-IM contraceptive product available for procurement
New beginnings @ConceptFNDN When I started working on the heat stable carbetocin project in 2012 at the Special Programme of Research on Human Reproduction (HRP), a public private partnership between WHO/HRP, Ferring Pharmaceuticals and MSD for Mothers I was...
Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results have been released, finally providing long awaited answers to questions about the relationship between DMPA, the Implant and the Copper IUD and risk of HIV transmission in women.
Access to quality magnesium sulfate and implementation of guidelines can help reduce maternal deaths due to preeclampsia. When a mother dies, the impact of her death reaches much further than the individual tragedy. It affects the life and health of the family,...
WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health
Appropriate Storage and Management of Oxytocin - a Key Commodity for Maternal Health
Access to Quality Assured generic Intramuscular DMPA continues to rise